Viewing Study NCT01076556

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:31 PM
Ignite Modification Date: 2026-05-23 @ 9:54 AM
Study NCT ID: NCT01076556
Status: TERMINATED
Last Update Posted: 2015-11-11
First Post: 2010-02-25
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Cyclophosphamide, Alvocidib, and Rituximab in Treating Patients With High Risk B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Lymphocytic Leukemia View
None Prolymphocytic Leukemia View
None Recurrent Small Lymphocytic Lymphoma View
None Refractory Chronic Lymphocytic Leukemia View
None Stage I Chronic Lymphocytic Leukemia View
None Stage I Small Lymphocytic Lymphoma View
None Stage II Chronic Lymphocytic Leukemia View
None Stage II Small Lymphocytic Lymphoma View
None Stage III Chronic Lymphocytic Leukemia View
None Stage III Small Lymphocytic Lymphoma View
None Stage IV Chronic Lymphocytic Leukemia View
None Stage IV Small Lymphocytic Lymphoma View
Keywords: